AHPA Handbook Update Bolsters Herb Safety Data for US Supplement Market
The updated AHPA Botanical Safety Handbook, 2nd edition, provides enhanced, rigorously vetted safety and drug interaction data for herbal ingredients. This resource is critical for US manufacturers navigating regulatory compliance and product development.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
Washington, D.C., United States
The American Herbal Products Association (AHPA) has released the second edition of its Botanical Safety Handbook, a significant update to the 1997 original. This revised edition provides a more robust, evidence-based platform for evaluating the safety of botanical ingredients, directly impacting US dietary supplement manufacturers and brand owners. The handbook maintains its core safety classification system, differentiating ingredients by usage appropriateness and contraindications. Crucially, the second edition introduces a new, separate three-tier classification system for potential herb-drug interactions, categorising ingredients based on whether clinically relevant interactions are expected, plausible, or known.
The update reflects a substantial shift in data compilation methodologies. While the first edition relied primarily on secondary references, the second edition leverages the internet and online scientific databases for a thorough review of primary literature. This has resulted in a vastly expanded evidence base; for example, specific entries like St. John's Wort now cite 301 references, compared to 280 references for over 500 plants in the initial release. This detailed approach aims to filter factual information from inaccuracies, addressing the challenge of unreferenced or biased data often found in historical records and even some peer-reviewed journals. The editors removed species where insufficient information prevented knowledgeable safety classification.
The handbook directly supports manufacturers' federal regulatory obligations to disclose known safety concerns. It explicitly refutes the 'natural is always safe' myth while acknowledging the general safety of many widely used culinary and traditional herbs. This balanced perspective provides a credible reference for both industry and regulators, promoting responsible product formulation and consumer communication.
What this means for United States
US supplement manufacturers can integrate the updated AHPA Handbook classifications into their product development and quality assurance protocols. The new drug interaction classifications support review of product formulations and enhanced caution labelling, particularly for products sold in retail channels like CVS or iHerb. Brand owners can leverage this enhanced safety data to differentiate products, mitigate regulatory scrutiny from the FDA, and strengthen consumer trust.
For more on UK formulation and manufacturing best practice, learn more at Supplement Factory.